Can a teenage girl taking metoprolol 25 mg daily for migraine prophylaxis experience fatigue at school?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Fatigue is a Well-Recognized Side Effect of Metoprolol

Tiredness and fatigue are common side effects of metoprolol, even at the low 25 mg dose used for migraine prevention in teenagers, and this can significantly impact school performance and quality of life. This is a known adverse effect of beta-blockers that should prompt consideration of alternative preventive therapies.

Why This Occurs

Beta-blockers like metoprolol reduce exercise capacity and can cause fatigue through multiple mechanisms:

  • Reduced maximal exercise power: Studies demonstrate that metoprolol significantly reduces maximal exercise capacity, with effects appearing as early as 1.5 hours after ingestion 1. This physiologic limitation translates to subjective fatigue during normal daily activities, including school.

  • Central nervous system penetration: Metoprolol crosses the blood-brain barrier, achieving CSF concentrations close to plasma levels 2. This central action likely contributes to fatigue and drowsiness.

  • Cardiovascular effects: By reducing heart rate and cardiac output, beta-blockers limit the body's ability to respond to physical and cognitive demands.

Clinical Context: Metoprolol Is NOT First-Line for Adolescent Migraine Prevention

Importantly, metoprolol is not among the recommended first-line preventive medications for adolescents with migraine. The 2020 AAN guidelines for pediatric migraine prevention specifically recommend discussing propranolol (not metoprolol), topiramate, and amitriptyline combined with cognitive behavioral therapy as evidence-based options 3.

The guidelines emphasize that:

  • Many preventive medications showed no benefit over placebo in pediatric trials
  • Side effects must be carefully weighed against uncertain efficacy
  • Approximately 30% of pediatric patients report adverse events from preventive medications 4

Common Adverse Effects in Adolescents

In pediatric populations taking migraine preventives, the most frequently reported side effects include 4:

  • Drowsiness (most common)
  • Fatigue
  • Anorexia
  • Paresthesia

Beta-blockers specifically are associated with exercise intolerance and tiredness, which can be particularly problematic for school-aged patients.

Recommended Action

Consider switching to propranolol if a beta-blocker is preferred, as it has Level B evidence for pediatric migraine prevention 3. However, propranolol also causes fatigue, so this may not resolve the issue.

Better alternatives include:

  • Topiramate: Has the strongest evidence for efficacy in pediatric migraine prevention, though it carries risks of cognitive side effects and weight loss
  • Amitriptyline combined with cognitive behavioral therapy: Evidence-supported combination
  • Non-pharmacologic approaches: Should always be emphasized first, including lifestyle modifications, trigger identification, and behavioral therapies

Important Caveats

  • The 2020 guidelines note that placebo response rates are very high in pediatric migraine trials, meaning many preventive medications show minimal benefit over placebo 3
  • Discuss with the patient and family whether continuing any preventive medication is worthwhile, given the side effect burden and uncertain efficacy
  • If fatigue is significantly impairing school performance, this represents a quality-of-life issue that outweighs potential migraine prevention benefits
  • Document the specific impact on school functioning (concentration, participation, attendance) to guide decision-making

The tiredness this teenager is experiencing is a predictable and well-documented side effect that warrants medication reassessment, particularly since metoprolol lacks strong evidence for use in this population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.